Finance

Beta
Lists
JBIO:NASDAQ
Jade Biosciences Inc
$22.79
+4.06%
(+0.89) 1D
Jun 25, 10:36:08 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JBIO...
Open
$22.00
High
$22.86
Low
$22.00
Mkt. cap
1.33B
Avg. vol.
1.20M
Volume
119.75K
52-wk high
$28.00
52-wk low
$6.67
EPS
-$2.41
Beta
1.45
Shares outstanding
60.86M
No. of employees
55
Open
$22.00
High
$22.86
Low
$22.00
Mkt. cap
1.33B
Avg. vol.
1.20M
Volume
119.75K
52-wk high
$28.00
52-wk low
$6.67
EPS
-$2.41
Beta
1.45
Shares outstanding
60.86M
No. of employees
55
News stories
From sources across the web
About Jade Biosciences Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitejadebiosciences.com
Analyst Ratings
Based on 10 analysts giving stock ratings to JBIO in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for JBIO in the last 3 months.
Highest
Current $22.79
$74.00 (+224.70%)
Average
$48.50 (+112.81%)
Lowest
$40.00 (+75.52%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Michael Yee
UBS
Buy
Initiated
$45.00
+97.5%
06/15/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$42.00
+84.3%
06/06/2026
Laura Chico
Wedbush
Buy
Maintained
$45.00
+97.5%
06/02/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$47.00
+106.2%
06/01/2026
Julian Harrison
BTIG
Buy
Maintained
$74.00
+224.7%
06/01/2026
Akash Tewari
Jefferies
Buy
Maintained
$40.00
+75.5%
06/01/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
06/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$55.00
+141.3%
06/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/08/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$40.00
+75.5%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.55M
22.01M
28.54M
36.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23M
5.39M
6.44M
7.39M
Operating expense
27.78M
27.40M
34.98M
43.44M
Total operating expenses
27.78M
27.40M
34.98M
43.44M
Operating income
-27.78M
-27.40M
-34.98M
-43.44M
Other non operating income
-
-28.00K
20.00K
-9.00K
EBT including unusual items
-32.13M
-25.18M
-31.87M
-40.35M
EBT excluding unusual items
-25.95M
-25.18M
-31.87M
-40.35M
Income tax expense
-
-
58.00K
16.00K
Effective tax rate
-
-
-0.18%
-0.04%
Other operating expenses
-
-
-
-
Net income
-32.13M
-25.18M
-31.93M
-40.37M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.83M
2.25M
3.08M
3.10M
Interest expense
-
-
-
-
Net interest expenses
1.83M
2.25M
3.08M
3.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.78M
-27.39M
-34.97M
-43.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer